MedPath

Metformin HCl

Metformin Hydrochloride Tablets USP

Approved
Approval ID

2a511607-04db-42d4-aa3c-8fa10e5ca050

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 10, 2023

Manufacturers
FDA

RPK Pharmaceuticals, Inc.

DUNS: 147096275

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metformin HCl

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53002-4422
Application NumberANDA090564
Product Classification
M
Marketing Category
C73584
G
Generic Name
Metformin HCl
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 7, 2017
FDA Product Classification

INGREDIENTS (9)

POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
METFORMIN HYDROCHLORIDEActive
Quantity: 850 mg in 1 1
Code: 786Z46389E
Classification: ACTIB
POVIDONE K90Inactive
Code: RDH86HJV5Z
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MALTODEXTRINInactive
Code: 7CVR7L4A2D
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Metformin HCl - FDA Drug Approval Details